Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

Visit Direct Link

You Might Also Like

Post comment